Cash Flow Statement

Currency: USD

	Mar-2012	Jun-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016
Operating Cash Flow
Net Income	(13)	(11)	(2)	(1)	1	0	9	9	2	(4)	(16)	(15)	(11)	(4)	(3)	(2)
Depreciation & Amortization	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0
Other Non-Cash Items	3	3	(2)	(3)	(3)	(3)	(2)	(0)	3	10	10	9	7	(0)	(0)	(0)
Cash Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Working Capital	4	1	(10)	(7)	(5)	2	(5)	(7)	(5)	(15)	(5)	(3)	(5)	(4)	(5)	(4)
Cash from Operating Activities	(5) N/A	(6) -10%	(13) -126%	(10) +22%	(6) +41%	(1) +91%	4 N/A	2 -44%	(0) N/A	(8) -2 543%	(10) -27%	(9) +8%	(9) +7%	(8) +9%	(7) +8%	(6) +17%
Investing Cash Flow
Capital Expenditures	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Investing Activities	(0) N/A	(0) N/A	(0) +9%	(0) -1%	(0) +55%	(0) N/A	(0) +76%	0 N/A	(0) N/A	(0) -140%	(0) -39%	(0) -88%	(0) +51%	0 N/A	0 +41%	0 +11%
Financing Cash Flow
Net Issuance of Common Stock	0	0	0	0	0	0	0	0	0	17	17	17	17	0	0	0
Net Issuance of Debt	0	0	0	0	0	0	0	6	6	6	6	0	0	0	0	0
Other	0	0	0	0	0	0	0	0	0	(3)	(3)	0	0	0	0	0
Cash from Financing Activities	0 N/A	0 N/A	0 N/A	0 +19%	0 N/A	0 N/A	0 -94%	6 +358 233%	6 +0%	21 +226%	21 +0%	15 -31%	15 0%	0 -100%	0 N/A	0 N/A
Change in Cash
Net Change in Cash	(5) N/A	(6) -10%	(13) -123%	(10) +22%	(6) +41%	(1) +91%	4 N/A	9 +123%	6 -30%	13 +113%	11 -17%	5 -53%	6 +15%	(8) N/A	(7) +9%	(6) +18%
Free Cash Flow
Free Cash Flow	(5) N/A	(6) -10%	(13) -124%	(10) +22%	(6) +41%	(1) +90%	4 N/A	2 -44%	(0) N/A	(8) -1 638%	(10) -27%	(10) +8%	(9) +8%	(8) +10%	(7) +9%	(6) +17%

Globeimmune Inc
OTC:GBIM